T-REX 2X Inverse CRWV Daily Target ETF (CORD) stock forecast & analysis
4.62
Cboe US · USD
Up: +1.08, +30.5%
1 analysis
Latest analysis: · verdict locked
- Open
- 4.09
- Previous close
- 3.54
- Day range
- 4.03 – 4.75
- 52-week range
- 1.87 – 67.55
- Volume (shares)
- 30.82M
- Net assets
- 19.95M
- Expense ratio
- 1.50%
- Shares outstanding
- Not available
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- Not available
- Market cap
- Not available
Market Scanner’s AI analysis of T-REX 2X Inverse CRWV Daily Target ETF (CORD), updated October 2026: CORD's recent analyses covered technical indicators suggesting short-term bullish momentum alongside news of spinal cord injury treatment advancements and steel cord market growth.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of T-REX 2X Inverse CRWV Daily Target ETF (CORD) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
CORD's recent analyses covered technical indicators suggesting short-term bullish momentum alongside news of spinal cord injury treatment advancements and steel cord market growth.
Recent analyses for CORD examined technical indicators, noting the current price above the 50-day SMA and positive short-term momentum signals from the 10-day EMA, MACD, and MFI. News coverage highlighted advancements in spinal cord injury treatments, including patient dosing in Phase 3 studies and positive interim data, as well as projections for the global steel cord market.
CORD news & sentiment
News coverage highlighted advancements in spinal cord injury treatments and growth projections for the steel cord market. Social media discussions were not covered in the provided notes.
CORD technical picture
CORD's price action showed a medium-term uptrend with the current price above the 50-day SMA, though significantly below the 200-day SMA indicating a long-term downtrend. Short-term momentum appeared positive, with the 10-day EMA below the current price and MACD showing a positive value. Momentum indicators like RSI and MFI neared overbought thresholds, suggesting potential short-term price exhaustion.
Fundamentals
Data for the income statement, balance sheet, and cash-flow statement were unavailable for CORD.
Factors discussed — upside
- Current price above 50-day SMA indicating medium-term uptrend
- 10-day EMA below current price suggesting short-term bullish momentum
- Positive MACD value indicating bullish momentum
- Strong buying pressure indicated by MFI nearing overbought conditions
- Advancements in spinal cord injury treatments and positive trial data
Factors discussed — risks
- Current price significantly below 200-day SMA suggesting long-term downtrend
- RSI nearing overbought threshold, suggesting potential short-term overextension
- MFI nearing overbought conditions
- Lack of available fundamental data (income statement, balance sheet, cash-flow)
- Technical indicators
- Spinal cord injury treatments
- Steel cord market growth
- Fundamental data availability
Summary updated .
CORD technical indicators
Common technical indicators for CORD, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 3.18 | Price above |
| 10-day exponential moving average | 3.40 | Price above |
| Relative strength index (14-day) | 68.72 | Neutral |
| MACD line (12/26/9) | 0.0593 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 2.26 – 3.98 | Price above the upper band |
Analyses
Recent CORD.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-10-15 CORD.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for T-REX 2X Inverse CRWV Daily Target ETF?
- The bull case for CORD centers on technical indicators showing a medium-term uptrend and short-term bullish momentum, supported by advancements in spinal cord injury treatments and positive trial data. Additionally, projections indicate growth in the global steel cord market.
- What are the risks for T-REX 2X Inverse CRWV Daily Target ETF?
- Risks for CORD include its current price being significantly below the 200-day SMA, suggesting a long-term downtrend, and technical indicators nearing overbought conditions. The lack of available fundamental financial data also presents a challenge.
- Is T-REX 2X Inverse CRWV Daily Target ETF bullish or bearish?
- Recent AI analyses of T-REX 2X Inverse CRWV Daily Target ETF examined factors on both sides. Discussed upside: The bull case for CORD centers on technical indicators showing a medium-term uptrend and short-term bullish momentum, supported by advancements in spinal cord injury treatments and positive trial data. Additionally, projections indicate growth in the global steel cord market. Discussed risks: Risks for CORD include its current price being significantly below the 200-day SMA, suggesting a long-term downtrend, and technical indicators nearing overbought conditions. The lack of available fundamental financial data also presents a challenge. These are descriptive observations, not a recommendation.
- What is the latest sentiment on T-REX 2X Inverse CRWV Daily Target ETF?
- News coverage highlighted advancements in spinal cord injury treatments and growth projections for the steel cord market. Social media discussions were not covered in the provided notes.
- How does Market Scanner analyse T-REX 2X Inverse CRWV Daily Target ETF?
- Every analysis of T-REX 2X Inverse CRWV Daily Target ETF runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for T-REX 2X Inverse CRWV Daily Target ETF?
The bull case for CORD centers on technical indicators showing a medium-term uptrend and short-term bullish momentum, supported by advancements in spinal cord injury treatments and positive trial data. Additionally, projections indicate growth in the global steel cord market.
What are the risks for T-REX 2X Inverse CRWV Daily Target ETF?
Risks for CORD include its current price being significantly below the 200-day SMA, suggesting a long-term downtrend, and technical indicators nearing overbought conditions. The lack of available fundamental financial data also presents a challenge.
Is T-REX 2X Inverse CRWV Daily Target ETF bullish or bearish?
Recent AI analyses of T-REX 2X Inverse CRWV Daily Target ETF examined factors on both sides. Discussed upside: The bull case for CORD centers on technical indicators showing a medium-term uptrend and short-term bullish momentum, supported by advancements in spinal cord injury treatments and positive trial data. Additionally, projections indicate growth in the global steel cord market. Discussed risks: Risks for CORD include its current price being significantly below the 200-day SMA, suggesting a long-term downtrend, and technical indicators nearing overbought conditions. The lack of available fundamental financial data also presents a challenge. These are descriptive observations, not a recommendation.
What is the latest sentiment on T-REX 2X Inverse CRWV Daily Target ETF?
News coverage highlighted advancements in spinal cord injury treatments and growth projections for the steel cord market. Social media discussions were not covered in the provided notes.
How does Market Scanner analyse T-REX 2X Inverse CRWV Daily Target ETF?
Every analysis of T-REX 2X Inverse CRWV Daily Target ETF runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh CORD.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.